Bigul

DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
20-04-2024
Bigul

Dr Reddy's rolls out condition management programme for irritable bowel syndrome

IBS is a functional gastrointestinal disorder characterised by abdominal pain, bloating and altered bowel habits
19-04-2024
Bigul

DR.REDDY'S LABORATORIES LTD. - 500124 - Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2024

Certiifcate under Regulation 40(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2024
19-04-2024
Bigul

DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
18-04-2024
Bigul

DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
13-04-2024
Next Page
Close

Let's Open Free Demat Account